(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 19.32% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.46%.
Cvrx's revenue in 2026 is $56,651,000.On average, 9 Wall Street analysts forecast CVRX's revenue for 2026 to be $1,740,749,608, with the lowest CVRX revenue forecast at $1,650,263,991, and the highest CVRX revenue forecast at $1,812,343,490. On average, 9 Wall Street analysts forecast CVRX's revenue for 2027 to be $2,084,195,014, with the lowest CVRX revenue forecast at $1,892,646,515, and the highest CVRX revenue forecast at $2,317,921,019.
In 2028, CVRX is forecast to generate $2,563,276,754 in revenue, with the lowest revenue forecast at $2,191,756,863 and the highest revenue forecast at $2,909,274,386.